AI predicts the likelihood of finding antidepressant helpful
New Scientist - 10-Feb-2020If developed, new research could help to improve the quality of mental disease treatments
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Developing a new generation of brain biomarker-based diagnostic tests and personalized treatments
Alto Neuroscience is a private company headquartered in Los Altos, CA. Alto is developing a new generation of biomarker-based diagnostic tests and personalized treatments for use in mental health, based on a platform built from data aggregated at scale and proprietary artificial intelligence analysis tools. The team combines world-leading neuroscientists and business executives with experience commercializing products for the brain.
Visit website: https://www.altoneuroscience.com/
See alsoDetails last updated 16-Feb-2020
If developed, new research could help to improve the quality of mental disease treatments